Cerebral microglial activation in patients with hepatitis c: In vivo evidence of neuroinflammation

Journal of Viral Hepatitis

Volumn 19, Issue 2, 2012, Pages

  Grover, V P B ^a,b   Pavese, N ^b   Koh, S B ^b,c   Wylezinska, M ^b   Saxby, B K ^d   Gerhard, A ^e   Forton, D M ^f   Brooks, D J ^b   Thomas, H C ^a   Taylor Robinson, S D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Korea University College of Medicine   (South Korea)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

cognitive function; hepatitis C; magnetic resonance spectroscopy; positron emission tomography

Indexed keywords

CARBON 11; CHOLINE; CREATINE; INOSITOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ADULT; ARTICLE; BASAL GANGLION; BINDING KINETICS; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ENCEPHALITIS; FATIGUE; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MACROPHAGE ACTIVATION; MALE; MICROGLIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THALAMUS; VIREMIA;

ADULT; AGED; BRAIN; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROGLIA; MIDDLE AGED;

EID: 84855852639     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01510.x     Document Type: Article

References (44)

1. Foster GR, Goldin RD, Thomas HC,. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatol 1998; 27 (1): 209-212.
2. Forton DM, Thomas HC, Murphy CA, et al., Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatol 2002; 35 (2): 433-439. (Pubitemid 34106386)
3. Weissenborn K, Krause J, Bokemeyer M, et al., Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41 (5): 845-851. (Pubitemid 39434316)
4. McAndrews MP, Farcnik K, Carlen P, et al., Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatol 2005; 41 (4): 801-808. (Pubitemid 40462942)
5. Hilsabeck RC, Perry W, Hassanein TI,. Neuropsychological impairment in patients with chronic hepatitis C. Hepatol 2002; 35 (2): 440-446. (Pubitemid 34106387)
6. Fontana RJ, Bieliauskas LA, Lindsay KL, et al., Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatol 2007; 45 (5): 1154-1163. (Pubitemid 46775777)
7. Gershon AS, Margulies M, Gorczynski RM, Heathcote EJ,. Serum cytokine values and fatigue in chronic hepatitis C infection. J Viral Hepatol 2000; 7 (6): 397-402.
8. Forton DM, Hamilton G, Allsop JM, et al., Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. J Hepatol 2008; 49 (3): 316-322.
9. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD,. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358 (9275): 38-39. (Pubitemid 32709741)
10. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC,. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78 (10): 5170-5183. (Pubitemid 38581469)
11. Vargas HE, Laskus T, Radkowski M, et al., Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002; 8 (11): 1014-1019. (Pubitemid 35363627)
12. Radkowski M, Wilkinson J, Nowicki M, et al., Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002; 76 (2): 600-608. (Pubitemid 34033359)
13. Letendre S, Paulino AD, Rockenstein E, et al., Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 2007; 196 (3): 361-370. (Pubitemid 47093886)
14. Wilkinson J, Radkowski M, Laskus T,. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 2009; 83 (3): 1312-1319.
15. Wilkinson J, Radkowski M, Eschbacher JM, Laskus T,. Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 2010; 59 (10): 1394-1400.
16. Ishak K, Baptista A, Bianchi L, et al., Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22 (6): 696-699.
17. 11C](R)-PK11195 PET in idiopathic Parkinson ' s disease. Neurobiol Dis 2006; 21 (2): 404-412. (Pubitemid 43099863)
18. Spinks TJ, Jones T, Bloomfield PM, et al., Physical characteristics of the ECAT EXACT3D positron tomograph. Phys Med Biol 2000; 45 (9): 2601-2618.
19. 11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 2001; 124 (Pt 10): 2014-2027. (Pubitemid 32945901)
20. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H,. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34 (5): 768-773. (Pubitemid 32488796)
21. Wesnes KA, McKeith IG, Ferrara R, et al., Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 2002; 13 (3): 183-192. (Pubitemid 34224938)
22. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF,. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl 1): S79-S83. (Pubitemid 24023890)
23. Mardini H, Saxby BK, Record CO,. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterol 2008; 135 (5): 1582-1590.
24. Hassoun Z, Willems B, Deslauriers J, Nguyen BN, Huet PM,. Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci 2002; 47 (12): 2674-2681. (Pubitemid 35471605)
25. Tai YF, Pavese N, Gerhard A, et al., Imaging microglial activation in Huntington ' s disease. Brain Res Bull 2007; 72 (2-3): 148-151. (Pubitemid 46389550)
26. Banati RB,. Visualising microglial activation in vivo. Glia 2002; 40 (2): 206-217. (Pubitemid 35337378)
27. 3H]PK 11195. Neurosci Lett 1994; 177 (1-2): 35-38. (Pubitemid 24269423)
28. 11C]-(R)-PK11195 in patients with AIDS. J Neurovirol 2005; 11 (4): 346-355. (Pubitemid 41614514)
29. Wiley CA, Lopresti BJ, Becker JT, et al., Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J Neurovirol 2006; 12 (4): 262-271. (Pubitemid 44382978)
30. Juengling FD, Ebert D, Gut O, et al., Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacol(Berl) 2000; 152 (4): 383-389.
31. Bakshi R, Thompson AJ, Rocca MA, et al., MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008; 7 (7): 615-625.
32. Grover VP, Dresner MA, Forton DM, et al., Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006; 12 (19): 2969-2978. (Pubitemid 43811072)
33. Bitsch A, Bruhn H, Vougioukas V, et al., Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999; 20 (9): 1619-1627. (Pubitemid 29498612)
34. Davie CA, Hawkins CP, Barker GJ, et al., Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993; 341 (8845): 630-631. (Pubitemid 23066176)
35. Avison MJ, Nath A, Berger JR,. Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci 2002; 25 (9): 468-473. (Pubitemid 35223001)
36. Bokemeyer M, Ding XQ, Goldbecker A, et al., Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut 2011; 60 (3): 370-377.
37. Panickar KS, Norenberg MD,. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005; 50 (4): 287-298. (Pubitemid 40780835)
38. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC,. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 1997; 175 (2): 478-481. (Pubitemid 27052263)
39. Norenberg MD, Itzhak Y, Bender AS,. The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv Exp Med Biol 1997; 420: 95-111. (Pubitemid 27396104)
40. Utter AA, Basso MA,. The basal ganglia: an overview of circuits and function. Neurosci Biobehav Rev 2008; 32 (3): 333-342. (Pubitemid 351192948)
41. Ito H, Inoue K, Goto R, et al., Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry. Ann Nucl Med 2006; 20 (2): 131-138.
42. Layrargues GP, Shapcott D, Spahr L, Butterworth RF,. Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab Brain Dis 1995; 10 (4): 353-356. (Pubitemid 26042543)
43. Forton DM, Allsop JM, Cox IJ, et al., A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 2005; 19 (Suppl 3): S53-S63. (Pubitemid 41682170)
44. McDonald EM, Mann AH, Thomas HC,. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet 1987; 2 (8569): 1175-1178.